Hypoxia Inhibits Proliferation of Human Dermal Lymphatic Endothelial Cells via Downregulation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Expression

Abstract

Objective

Lymphatic endothelial cell (LEC) proliferation is essential for lymphangiogenesis. Hypoxia induces lymphangiogenesis, but it directly inhibits LEC proliferation and the underlying mechanisms have not been fully understood. The aim of this study was to investigate the role of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in hypoxia-repressed LEC proliferation.

Methods

Human dermal lymphatic endothelial cells (HDLECs) were cultured under normoxic or hypoxic conditions, and cell proliferation was determined using MTT or CCK-8 assays. CEACAM1 expression was silenced by siRNA transfection. Activation of mitogen-activated protein kinases (MAPKs) was examined by Western blotting and blocked by specific inhibitors.

Results

Under hypoxia, HDLECs proliferation was suppressed and CEACAM1 expression was downregulated. Silence of CEACAM1 in normoxia inhibited HDLECs proliferation and did not further decrease proliferation in HDLECs in response to hypoxia, suggesting that CEACAM1 may mediate hypoxia-induced inhibition of HDLECs proliferation. In addition, silence of CEACAM1 increased phosphorylation of MAPK molecules: extracellular signal-regulated kinase (ERK), p38 MAPK and Jun N-terminal kinase (JNK) in HDLECs. However, only inhibition of the JNK pathway rescued the reduction of HDLEC proliferation induced by CEACAM1 silence.

Conclusion

Our results suggested that hypoxia downregulates CEACAM1 expression by activation of the JNK pathway, leading to inhibition of HDLEC proliferation. These findings may help to understand the mechanisms of LEC-specific response to hypoxia and develop novel therapies for pathological lymphangiogenesis.

Keywords

lymphatic endothelial cell / hypoxia / proliferation / carcinoembryonic antigen-related cell adhesion molecule 1 / Jun N-terminal kinase pathway

References

[1] JiRC. Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci, 2012, 69(6): 897-914

[2] StackerSA, WilliamsSP, KarnezisT, et al.. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer, 2014, 14(3): 159-172

[3] AlitaloK, TammelaT, PetrovaTV. Lymphangiogenesis in development and human disease. Nature, 2005, 438(7070): 946-953

[4] TammelaT, AlitaloK. Lymphangiogenesis: Molecular mechanisms and future promise. Cell, 2010, 140(4): 460-476

[5] SormendiS, WielockxB. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment. Front Immunol, 2018, 9: 40

[6] SemenzaG L. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene, 2013, 32(35): 4057-4063

[7] AlitaloK, CarmelietP. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell, 2002, 1(3): 219-227

[8] MaC, LiuY, WangY, et al.. Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1/2 signalling. Br J Pharmacol, 2014, 171(14): 3352-3363

[9] IrigoyenM, AnsoE, MartinezE, et al.. Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta, 2007, 1773(6): 880-890

[10] XieQ, ChenX, XuY, et al.. CEACAM1 resists hypoxia-induced inhibition of tube formation of human dermal lymphatic endothelial cells. Cell Signal, 2018, 45: 145-152

[11] Gray-OwenSD, BlumbergRS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol, 2006, 6(6): 433-446

[12] NouvionAL, OubahaM, LeblancS, et al.. CEACAM1: a key regulator of vascular permeability. J Cell Sci, 2010, 123: 4221-4230 Pt 24

[13] KilicN, Oliveira-FerrerL, Neshat-VahidS, et al.. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood, 2007, 110(13): 4223-4233

[14] SingerBB, KlaileE, ScheffrahnI, et al.. CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur J Immunol, 2005, 35(6): 1949-1959

[15] GreiciusG, SeverinsonE, BeaucheminN, et al.. CEACAM1 is a potent regulator of B cell receptor complex-induced activation. J Leukoc Biol, 2003, 74(1): 126-134

[16] GerstelD, WegwitzF, JannaschK, et al.. CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. Oncogene, 2011, 30(41): 4275-4288

[17] LiL, DongF, XuD, et al.. Short-term, low-dose cadmium exposure induces hyperpermeability in human renal glomerular endothelial cells. J Appl Toxicol, 2016, 36(2): 257-265

[18] ChengDD, ZhuB, LiSJ, et al.. Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway. J Cancer, 2017, 8(14): 2720-2728

[19] ErnensI, LumleyAI, ZhangL, et al.. Hypoxia inhibits lymphatic thoracic duct formation in zebrafish. Biochem Biophys Res commun, 2017, 482(4): 1129-1134

[20] JiRC. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Lett, 2014, 346(1): 6-16

[21] WeiT, JiaJ, WadaY, et al.. Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget, 2017, 8(27): 44 944-44 959

[22] MorfoisseF, RenaudE, HantelysF, et al.. Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis. Mol Cell Oncol, 2015, 2(4): e1024821

[23] HorstA K, ItoW D, DabelsteinJ, et al.. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest, 2006, 116(6): 1596-1605

[24] ZhangJ, GuoL, ZhouX, et al.. Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway. Oncology Lett, 2016, 12(3): 1896-1900

[25] ChenX, XuY, ChengZ, et al.. Low-dose cadmium activates the JNK signaling pathway in human renal podocytes. Int J Mol Med, 2018, 41(4): 2359-2365